Tenaya Therapeutics, Inc.
TNYA
$0.88
$0.033.19%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 0.49% | 12.92% | 13.33% | -12.70% | 7.01% |
| Total Depreciation and Amortization | -1.98% | -10.56% | -21.68% | 27.38% | -0.57% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -5.84% | -18.48% | 1.17% | 2.98% | -12.35% |
| Change in Net Operating Assets | 196.96% | -191.46% | 129.32% | -231.56% | 21.34% |
| Cash from Operations | 10.64% | 0.09% | 32.45% | -25.69% | 7.30% |
| Capital Expenditure | -157.69% | 81.69% | 62.92% | -87.75% | -10.87% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | -64.64% | 10.78% | 58.56% | 147.83% |
| Cash from Investing | -100.76% | -64.54% | 12.04% | 58.14% | 146.86% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 15,226.84% | -- | -- | 13,231.30% | 1,116.13% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 15,226.84% | 179.83% | -100.95% | 13,231.30% | 1,116.13% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 795.63% | -171.46% | -82.00% | 1,365.33% | 92.17% |